A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors

EMBO Journal

Volumn 31, Issue 18, 2012, Pages 3704-3717

  Vicente Duenas, Carolina ^a,b   Romero Camarero, Isabel ^a,b   González Herrero, Inés ^a,b   Alonso Escudero, Esther ^a,b   Abollo Jiménez, Fernando ^a,b   Jiang, Xiaoyu ^c   Gutierrez, Norma C ^b,d   Orfao, Alberto ^b,e   Marín, Nieves ^f   Villar, Luisa María ^f   Criado, Ma Carmen Fernández ^g   Pintado, Belnn ^h   Flores, Teresa ^a,b   Alonso López, Diego ⁱ   De Las Rivas, Javier ^i,j   Jiménez, Rafael ^a,b   Criado, Francisco Javier García ^a,b   Cenador, María Begona García ^a,b   Lossos, Izidore S ^c,k   Cobaleda, César ^g   Sánchez García, Isidro ^a,b   more..

^a UNIVERSITY OF SALAMANCA   (Spain)

^b INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA IBSAL   (Spain)

^c UNIVERSITY OF MIAMI   (United States)

^d HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^e UNIVERSITY OF SALAMANCA   (Spain)

^f HOSPITAL RAMÓN Y CAJAL   (Spain)

^g UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^h CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

ⁱ Centro de Investigacion del Cancer   (Spain)

^j CSIC   (Spain)

^k UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

more..

Author keywords

cancer therapy; MafB; multiple myeloma mouse model; oncogenes; reprogramming stem cells

Indexed keywords

ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEMATOPOIETIC CELL; MOUSE; MULTIPLE MYELOMA; NONHUMAN; ONCOGENE; ONCOGENE MAFB; PLASMA CELL; PRIORITY JOURNAL; STEM CELL;

ANIMALS; ANTIGENS, CD34; ANTIGENS, LY; B-LYMPHOCYTES; DNA METHYLATION; DNA, COMPLEMENTARY; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE LIBRARY; HEMATOPOIETIC STEM CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MAFB TRANSCRIPTION FACTOR; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MULTIPLE MYELOMA; TRANSLOCATION, GENETIC;

ANIMALIA; MUS MUSCULUS;

EID: 84866370627     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2012.227     Document Type: Article

References (64)

1. Abollo-Jimenez F, Jimenez R, Cobaleda C (2010) Physiological cellular reprogramming and cancer. Semin Cancer Biol 20: 98-106
2. Artner I, Blanchi B, Raum JC, Guo M, Kaneko T, Cordes S, Sieweke M, Stein R (2007) MafB is required for islet beta cell maturation. Proc Natl Acad Sci USA 104: 3853-3858 (Pubitemid 47181543)
3. Bhatla T, Wang J, Morrison DJ, Raetz EA, Burke MJ, Brown P, Carroll WL (2012) Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosen-sitivity in childhood B-lymphoblastic leukemia. Blood 119: 5201-5210
4. Blair A, Sutherland HJ (2000) Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117). Exp Hematol 28: 660-671 (Pubitemid 30398523)
5. Blanchi B, Kelly LM, Viemari JC, Lafon I, Burnet H, Bevengut M, Tillmanns S, Daniel L, Graf T, Hilaire G, Sieweke MH (2003) MafB deficiency causes defective respiratory rhythmogenesis and fatal central apnea at birth. Nat Neurosci 6: 10 91-1100
6. Bock C, Tomazou EM, Brinkman AB, Muller F, Simmer F, Gu H, Jager N, Gnirke A, Stunnenberg HG, Meissner A (2010) Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat Biotechnol 28: 1106-1114
7. Casey G, Smith R, McGillivray D, Peters G, Dickson C (1986) Characterization and chromosome assignment of the human homolog of int-2, a potential proto-oncogene. Mol Cell Biol 6: 502-510 (Pubitemid 16158124)
8. Castellanos A, Vicente-Duenas C, Campos-Sanchez E, Cruz JJ, Garcia-Criado FJ, Garcia-Cenador MB, Lazo PA, Perez-Losada J, Sanchez-Garcia I (2010) Cancer as a reprogramming-like disease: implications in tumor development and treatment. Semin Cancer Biol 20: 93-97
9. Cobaleda C, Sanchez-Garcia I (2009) B-cell acute lymphoblastic leukaemia: towards understanding its cellular origin. BioEssays 31 : 600-609
10. Chen Y, Shi L, Zhang L, Li R, Liang J, Yu W, Sun L, Yang X, Wang Y, Zhang Y, Shang Y (2008) The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer. J Biol Chem 283: 17969-17978
11. Deneault E, Cellot S, Faubert A, Laverdure JP, Frechette M, Chagraoui J, Mayotte N, Sauvageau M, Ting SB, Sauvageau G (2009) A functional screen to identify novel effectors of hemato-poietic stem cell activity. Cell 137: 369-379
12. Ema H, Nakauchi H (2003) Self-renewal and lineage restriction of hematopoietic stem cells. Curr Opin Genet Dev 13: 508-512 (Pubitemid 37204928)
13. Eychene A, Rocques N, Pouponnot C (2008) A new MAFia in cancer. Nat Rev Cancer 8: 683-693
14. Gemelli C, Montanari M, Tenedini E, Zanocco Marani T, Vignudelli T, Siena M, Zini R, Salati S, Tagliafico E, Manfredini R, Grande A, Ferrari S (2006) Virally mediated MafB transduction induces the monocyte commitment of human CD34 + hemato-poietic stem/progenitor cells. Cell Death Differ 13: 1686-1696 (Pubitemid 44390856)
15. Gu H, Smith ZD, Bock C, Boyle P, Gnirke A, Meissner A (2011) Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling. Nat Protoc 6: 468-481
16. Hamburger A, Salmon SE (1977) Primary bioassay of human myeloma stem cells. J Clin Invest 60: 846-854 (Pubitemid 8208477)
17. Hideshima T, Mitsiades C, Tonon G, Richardson PG, Anderson KC (2007) Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer 7: 585-598 (Pubitemid 47106630)
18. Hurt EM, Wiestner A, Rosenwald A, Shaffer AL, Campo E, Grogan T, Bergsagel PL, Kuehl WM, Staudt LM (2004) Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma. Cancer Cell 5: 191-199 (Pubitemid 38283804)
19. Iida S, Rao PH, Butler M, Corradini P, Boccadoro M, Klein B, Chaganti RS, Dalla-Favera R (1997) Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat Genet 17: 226-230
20. Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) WHO Classification of Tumours. In Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, Vol. 3, pp 142-154. Lyon, France: International Agency for Research on Cancer (IARC)
21. Kataoka K, Fujiwara KT, Noda M, Nishizawa M (1994) MafB, a new Maf family transcription activator that can associate with Maf and Fos but not with Jun. Mol Cell Biol 14: 7581-7591 (Pubitemid 24326424)
22. Kelly LM, Englmeier U, Lafon I, Sieweke MH, Graf T (2000) MafB is an inducer of monocytic differentiation. EMBO J 19: 1987-1997 (Pubitemid 30237574)
23. Kikushige Y, Ishikawa F, Miyamoto T, Shima T, Urata S, Yoshimoto G, Mori Y, Iino T, Yamauchi T, Eto T, Niiro H, Iwasaki H, Takenaka K, Akashi K (2011) Self-renewing hemato-poietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell 20: 246-259
24. Lessard J, Sauvageau G (2003) Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423: 255-260 (Pubitemid 40852690)
25. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat ML, Gyorki DE, Ward T, Partanen A, Feleppa F, Huschtscha LI, Thorne HJ, Fox SB, Yan M, French JD, Brown MA, Smyth GK, Visvader JE, Lindeman GJ (2009) Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15: 907-913
26. Lopez-Corral L, Gutierrez NC, Vidriales MB, Mateos MV, Rasillo A, Garcia-Sanz R, Paiva B, San Miguel JF (2011) The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells. Clin Cancer Res 17: 1692-1700
27. Mak AB, Nixon AM, Moffat J (2012) The mixed lineage leukemia (MLL) fusion-associated gene AF4 promotes CD133 transcription. Cancer Res 72: 1929-1934
28. Matsui W, Huff CA, Wang Q, Malehorn MT, Barber J, Tanhehco Y, Smith BD, Civin CI, Jones RJ (2004) Characterization of clono-genic multiple myeloma cells. Blood 103: 2332-2336 (Pubitemid 38326254)
29. Matsui W, Wang Q, Barber JP, Brennan S, Smith BD, Borrello I, McNiece I, Lin L, Ambinder RF, Peacock C, Watkins DN, Huff CA, Jones RJ (2008) Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res 68: 190-197 (Pubitemid 351380120)
30. Matsumura Y, Tarin D (1992) Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340: 1053-1058
31. Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, Zhang X, Bernstein BE, Nusbaum C, Jaffe DB, Gnirke A, Jaenisch R, Lander ES (2008) Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454: 766-770
32. Miles C, Sanchez MJ, Sinclair A, Dzierzak E (1997) Expression of the Ly-6E.1 (Sca-1) transgene in adult hematopoietic stem cells and the developing mouse embryo. Development 124: 537-547 (Pubitemid 27101687)
33. Mitsiades CS, Mitsiades N, Munshi NC, Anderson KC (2004) Focus on multiple myeloma. Cancer Cell 6: 439-444 (Pubitemid 39469979)
34. Molyneux G, Geyer FC, Magnay FA, McCarthy A, Kendrick H, Natrajan R, Mackay A, Grigoriadis A, Tutt A, Ashworth A, Reis-Filho JS, Smalley MJ (2010) BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 7: 403-417
35. Morito N,Yoh K,Fujioka Y,Nakano T,Shimohata H,Hashimoto Y,Yamada A,Maeda A,Matsuno F,Hata H,Suzuki A,Imagawa S,Mitsuya H, Esumi H, Koyama A, Yamamoto M, Mori N, Takahashi S (2006) Overexpression of c-Maf contributes to T-cell lymphoma in both mice and human. Cancer Res 66: 812-819 (Pubitemid 43165946)
36. Morito N, Yoh K, Maeda A, Nakano T, Fujita A, Kusakabe M, Hamada M, Kudo T, Yamagata K, Takahashi S (2011) A novel transgenic mouse model of the human multiple myeloma chromosomal translocation t(14;16)(q32;q23). Cancer Res 71: 339-348
37. Neering SJ, Bushnell T, Sozer S, Ashton J, Rossi RM, Wang PY, Bell DR, Heinrich D, Bottaro A, Jordan CT (2007) Leukemia stem cells in a genetically defined murine model of blast-crisis CML. Blood 11 0 : 2578-2585 (Pubitemid 47523181)
38. Ng AP, Wei A, Bhurani D, Chapple P, Feleppa F, Juneja S (2006) The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells. Haematologica 91: 972-975 (Pubitemid 44023155)
39. Nishimura W, Rowan S, Salameh T, Maas RL, Bonner-Weir S, Sell SM, Sharma A (2008) Preferential reduction of beta cells derived from Pax6-MafB pathway in MafB deficient mice. Dev Biol 314: 443-456
40. Nishizawa M, Kataoka K, Vogt PK (2003) MafA has strong cell transforming ability but is a weak transactivator. Oncogene 22: 7882-7890 (Pubitemid 37175852)
41. Okita K, Ichisaka T, Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317 (Pubitemid 47080336)
42. Orfao A, Garcia-Sanz R, Lopez-Berges MC, Belen Vidriales M, Gonzalez M, Caballero MD, San Miguel JF (1994) A new method for the analysis of plasma cell DNA content in multiple myeloma samples using a CD38/propidium iodide double staining technique. Cytometry 17: 332-339
43. Perez-Caro M, Cobaleda C, Gonzalez-Herrero I, Vicente-Duenas C, Bermejo-Rodriguez C, Sanchez-Beato M, Orfao A, Pintado B, Flores T, Sanchez-Martin M, Jimenez R, Piris MA, Sanchez-Garcia I (2009) Cancer induction by restriction of oncogene expression to the stem cell compartment. Embo J 28: 8-20
44. Pouponnot C, Sii-Felice K, Hmitou I, Rocques N, Lecoin L, Druillennec S, Felder-Schmittbuhl MP, Eychene A (2006) Cell context reveals a dual role for Maf in oncogenesis. Oncogene 25: 1299-1310 (Pubitemid 43336458)
45. Rowland BD, Bernards R, Peeper DS (2005) The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 7: 1074-1082
46. Sanchez-Garcia I (1997) Consequences of chromosomal abnormalities in tumor development. Annu Rev Genet 31 : 429-453 (Pubitemid 28023715)
47. Sanchez-Garcia I (2010) Getting to the stem of cancer. Semin Cancer Biol 20: 63-64
48. Sarrazin S, Mossadegh-Keller N, Fukao T, Aziz A, Mourcin F, Vanhille L, Kelly Modis L, Kastner P, Chan S, Duprez E, Otto C, Sieweke MH (2009) MafB restricts M-CSF-dependent myeloid commitment divisions of hematopoietic stem cells. Cell 138: 300-313
49. Shearstone JR, Pop R, Bock C, Boyle P, Meissner A, Socolovsky M (2011) Global DNA demethylation during mouse erythropoiesis in vivo. Science 334: 799-802
50. Sieweke MH, Tekotte H, Frampton J, Graf T (1996) MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation. Cell 85: 49-60 (Pubitemid 26116806)
51. Silva F, Carvalho F, Peixoto A, Seixas M, Almeida R, Carneiro F, Mesquita P, Figueiredo C, Nogueira C, Swallow DM, Amorim A, David L (2001) MUC1 gene polymorphism in the gastric carcino-genesis pathway. Eur J Hum Genet 9: 548-552 (Pubitemid 32750496)
52. Taipale J, Beachy PA (2001) The Hedgehog and Wnt signalling pathways in cancer. Nature 411: 349-354 (Pubitemid 32467044)
53. Tanaka Y, Era T, Nishikawa S, Kawamata S (2007) Forced expression of Nanog in hematopoietic stem cells results in a gammadeltaT-cell disorder. Blood 11 0 : 107-115 (Pubitemid 47026825)
54. Tosi P, Gamberi B, Giuliani N (2006) Biology and treatment of multiple myeloma. Biol Blood Marrow Transplant 12: 81-86 (Pubitemid 43034125)
55. van de Donk NW, Lokhorst HM, Bloem AC (2005) Growth factors and antiapoptotic signaling pathways in multiple myeloma. Leukemia 19: 2177-2185 (Pubitemid 41741612)
56. van Stralen E, van de Wetering M, Agnelli L, Neri A, Clevers HC, Bast BJ (2009) Identification of primary MAFB target genes in multiple myeloma. Exp Hematol 37: 78-86
57. Vicente-Duenas C, Barajas-Diego M, Romero-Camarero I, Gonzalez-Herrero I, Flores T, Sanchez-Garcia I (2012) Essential role for telomerase in chronic myeloid leukemia induced by BCR-ABL in mice. Oncotarget 3: 261-266
58. Visvader JE (2011) Cells of origin in cancer. Nature 469: 314-322
59. Vonlanthen S, Heighway J, Altermatt HJ, Gugger M, Kappeler A, Borner MM, van Lohuizen M, Betticher DC (2001) The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer 84: 1372-1376 (Pubitemid 32522106)
60. Wei X, Xu H, Kufe D (2006) MUC1 oncoprotein stabilizes and activates estrogen receptor alpha. Mol Cell 21: 295-305 (Pubitemid 43099944)
61. Williams GT (1991) Programmed cell death: apoptosis and oncogenesis. Cell 65: 1097-1098 (Pubitemid 121001323)
62. Zhan F, Hardin J, Kordsmeier B, Bumm K, Zheng M, Tian E, Sanderson R, Yang Y, Wilson C, Zangari M, Anaissie E, Morris C, Muwalla F, van Rhee F, Fassas A, Crowley J, Tricot G, Barlogie B, Shaughnessy Jr J (2002) Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood 99: 1745-1757 (Pubitemid 34533050)
63. Zhan F, Huang Y, Colla S, Stewart JP, Hanamura I, Gupta S, Epstein J, Yaccoby S, Sawyer J, Burington B, Anaissie E, Hollmig K, Pineda-Roman M, Tricot G, van Rhee F, Walker R, Zangari M, Crowley J, Barlogie B, Shaughnessy Jr JD (2006) The molecular classification of multiple myeloma. Blood 108: 2020-2028 (Pubitemid 44395016)
64. Zhan F, Tian E, Bumm K, Smith R, Barlogie B, Shaughnessy Jr J (2003) Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development. Blood 101 : 1128-1140 (Pubitemid 36139388)